- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ovarian Reserve in United Kingdom
Total 2468 results
-
Daniela Matei, MDSanofi; Novartis Pharmaceuticals; Walther Cancer InstituteCompletedOvarian CancerUnited States
-
University of California, San FranciscoDexCom, Inc.RecruitingInsulin Resistance | Dysglycemia | PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesUnited States
-
Janssen Research & Development, LLCCompletedNeoplasmsUnited States, Spain, Canada, Belgium
-
GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, OvarianUnited States, Australia, Singapore
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCCompletedOvarian CancerUnited States
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity Cancer | Fallopian Tube AdenocarcinomaUnited States
-
HonorHealth Research InstituteMerck Sharp & Dohme LLC; Salarius Pharmaceuticals, LLCWithdrawnOvarian Endometrioid Adenocarcinoma | Endometrial Cancer | SCCOHT | Ovarian Clear Cell TumorUnited States
-
COL George Peoples, MD, FACSCompletedOvarian Cancer | Endometrial Cancer | Peritoneal Cancer | Fallopian CancerUnited States
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
Gradalis, Inc.Completed
-
Craig L Slingluff, JrNational Cancer Institute (NCI)TerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCCompletedOvarian Cancer | Endometrial CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Transitional Care PlanningUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingOvarian Cancer | Ovarian CarcinomaUnited States
-
Robert EdwardsMerck Sharp & Dohme LLC; AIM ImmunoTech Inc.RecruitingOvarian Cancer RecurrentUnited States
-
University of MiamiMerck Sharp & Dohme LLCTerminatedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneum CancerUnited States
-
Floor BackesEisai Inc.CompletedFallopian Tube Carcinoma | Recurrent Endometrial Cancer | Primary Peritoneal Carcinoma | Recurrent Ovarian CancerUnited States
-
National Cancer Institute (NCI)CompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Primary Peritoneal NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
Genelux CorporationGOG FoundationRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Platinum-refractory Ovarian Cancer | Primary Peritoneal Cancer | High-grade Serous Ovarian Cancer | Endometrioid Ovarian Cancer | Ovarian Clear Cell CarcinomaUnited States
-
Cancer Research UKTerminatedBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited Kingdom
-
M.D. Anderson Cancer CenterAstraZeneca; Aravive Biologics IncActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedTesticular Seminoma | Recurrent Ovarian Germ Cell Tumor | Stage II Ovarian Germ Cell Tumor | Stage III Ovarian Germ Cell Tumor | Ovarian Dysgerminoma | Recurrent Malignant Testicular Germ Cell Tumor | Stage II Malignant Testicular Germ Cell Tumor | Stage III Malignant Testicular Germ Cell TumorUnited States
-
Seagen Inc.GenmabCompletedProstate Cancer | Squamous Cell Carcinoma of the Head and Neck | Bladder Cancer | Cervix Cancer | Lung Cancer, Nonsmall Cell | Ovary Cancer | Esophagus Cancer | Endometrium CancerUnited States, United Kingdom
-
Abramson Cancer Center at Penn MedicineRecruitingSuspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerUnited States
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
University of Southern CaliforniaStanford UniversityCompletedHereditary Breast and Ovarian CancerUnited States
-
Ohio State UniversityUnited States Department of DefenseRecruitingHeart Failure With Preserved Ejection FractionUnited States
-
University of Texas Southwestern Medical CenterCompletedHeart Failure With Preserved Ejection FractionUnited States
-
University of Alabama at BirminghamGlaxoSmithKlineTerminatedOvarian CancerUnited States
-
NYU Langone HealthNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedOvarian CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Sprint for LifeCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma and other conditionsUnited States
-
AdaptimmuneCompleted
-
National Cancer Institute (NCI)RecruitingRecurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian CarcinomaUnited States
-
ImmunoGen, Inc.Active, not recruitingFallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Ovarian CancerUnited States, United Kingdom, Belgium, Spain, Canada, Georgia
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedQuality of Life | Ovarian Cancer | Malignant Tumor of PeritoneumUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); University of Pittsburgh; AIM ImmunoTech Inc.SuspendedOvarian Cancer | Cancer of the Ovary | Ovary Cancer | Neoplasms, Ovarian | Ovary Neoplasms | Cancer of OvaryUnited States
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States
-
Women and Infants Hospital of Rhode IslandTerminatedBreast Cancer | Ovarian CancerUnited States
-
University of California, San FranciscoCompletedPolycystic Ovarian SyndromeUnited States
-
Duke UniversityCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Refractory Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Stage IV Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Stage IIA Fallopian Tube Cancer | Stage... and other conditionsUnited States
-
Merrimack PharmaceuticalsSanofiCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States
-
Precigen, IncRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Stage III Fallopian Tube... and other conditionsUnited States
-
Ludwig Institute for Cancer ResearchCelgene; Cancer Research Institute, New York City; MedImmune LLCCompletedOvarian CancerUnited States, Switzerland
-
Johnson & Johnson Pharmaceutical Research & Development...PharmaMarCompletedOvarian CancerUnited States, France, Poland, United Kingdom, China, Belgium, Germany, Hong Kong, Taiwan, Spain, Canada, Netherlands, Sweden, Korea, Republic of, Singapore, Russian Federation, Argentina, Brazil, Chile, Australia
-
OncoMed Pharmaceuticals, Inc.Completed